Overview

An Observational Study of Chinese Multiple Myeloma Patients Treated With Velcade

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to acquire information on the usage, effectiveness, safety, and levels of health care resource utilization associated with Velcade therapy in recurrent and refractory multiple myeloma patients who are initiating Velcade and various combination therapies within the approved indication in a naturalistic setting.
Details
Lead Sponsor:
Xian-Janssen Pharmaceutical Ltd.
Treatments:
Bortezomib